Tag - medicine

 
 

MEDICINE

Japan Times
BUSINESS / Companies
Aug 4, 2021
SoftBank built a $5 billion stake in pharma giant Roche
Roche's diagnostics unit reacted swiftly to the pandemic, and now sales are boosted by its COVID-19 testing business.
Japan Times
COMMENTARY / World
Aug 2, 2021
More shots alone won’t win the global war on variants
The delta COVID-19 variant is tipping the pandemic into a frightening new stage and vaccination efforts are unable to keep up.
Japan Times
COMMENTARY / World
Jul 30, 2021
Legitimate pain research is more crucial than ever
Researchers today say opioids are not only dangerous; they are not a good long-term solution for chronic pain sufferers. The relief tends to wane with time.
Japan Times
JAPAN
Jul 29, 2021
Even with delta surging, experts say two vaccine doses is enough for now
U.S. firm Pfizer Inc. has called for an additional third shot of its COVID-19 vaccine, citing new data showing its efficacy tails off after six months.
Japan Times
COMMENTARY / World
Jul 29, 2021
How behavioral economics views mask mandates
What we know from behavioral economics suggests that universal mask requirements will undermine the effort to get as many people as possible vaccinated.
Japan Times
WORLD / Science & Health
Jul 29, 2021
Doctors blast Biogen Alzheimer approval as ‘regulatory failure’
The New England Journal of Medicine opinion piece is another sign of persistent furor over the agency's decision.
Japan Times
COMMENTARY / World
Jul 26, 2021
London’s delta surge should jolt New York
A big question is whether New York, another large city that has reopened after having been through the COVID-19 wringer in 2020, will face a similar resurgence of cases like London.
Japan Times
COMMENTARY / World
Jul 22, 2021
At this point, the U.K.'s COVID-19 rules follow politics as much as science
If the last 18 months have taught us anything, it's that a successful COVID-19 policy requires three things: high levels of public trust, a coherent strategy and effective implementation.
Japan Times
COMMENTARY / World
Jul 21, 2021
As delta variant rages in Southeast Asia, health workers warned not to speak out
In Southeast Asian nations, health care providers calling for stronger job security and better protection against variants of the coronavirus, have put governments on the defensive.
Japan Times
WORLD / FOCUS
Jul 16, 2021
World carved up into haves and have-nots by mRNA vaccine access
The cutting-edge technology, which made its debut during the pandemic, has proven more effective than any other in staving off infections and serious illness from the coronavirus.
Japan Times
BUSINESS / Companies
Jul 13, 2021
Eisai pushes second Alzheimer's drug despite call to probe U.S. approval of first
The U.S. Food and Drug Administration's June approval of Aduhelm caused resignations among a panel of independent experts who said the therapy was ineffective.
Japan Times
WORLD
Jul 9, 2021
Pfizer outlines booster plans while regulators signal caution
Pfizer Inc. plans to request U.S. emergency authorization in August for a third booster dose of its COVID-19 vaccine.
Japan Times
WORLD
Jul 9, 2021
Countries using Chinese-made vaccines and AstraZeneca increasingly eye boosters
Officials are being motivated by concerns that delta and other variants appear to be breaking down defenses of vaccines not made from the supereffective messenger RNA technology.
Japan Times
WORLD / Science & Health
Jul 7, 2021
Studies show vaccines are effective against delta variant
Jerusalem, however, announced that the effectiveness of the Pfizer-BioNTech vaccine was seen to be 64% against all COVID-19 infections — down from about 95% in May.
Japan Times
JAPAN
Jun 29, 2021
In Japan, anti-vaccine movement threatens to make widespread hesitancy worse
“Zero-risk worship” in Japan has made experts concerned about the impact that a fringe community of outspoken vaccine opponents could have on the public.
Japan Times
WORLD
Jun 28, 2021
Pfizer and Moderna vaccines likely produce long-lasting immunity
The findings add to growing evidence that most people immunized with mRNA vaccines may not need boosters, so long as the virus and its variants do not evolve much.
Japan Times
WORLD
Jun 25, 2021
WHO estimates COVID-19 boosters needed yearly for most vulnerable
A document shows that the WHO considers annual boosters for high-risk individuals as its 'indicative' baseline scenario, and boosters every two years for the general population.
Japan Times
COMMENTARY / World
Jun 22, 2021
Face masks were a booming business. Until they weren’t.
Face masks were the most ubiquitous visual symbol of the COVID-19 pandemic, but they're fading from sight as more and more people get vaccinated.

Longform

Construction takes place on the Takanawa Gateway Convention Center in Tokyo, slated to open in 2025.
A boom for business tourism in Japan?